Skip to main content
SpringerLink
Log in

Hypertensive Herzerkrankung, Linksherzhypertrophie und Herzklappeninsuffizienz

Seltene Ursache der Symptomtrias

Hypertensive heart disease, left ventricular hypertrophy and cardiac valve insufficiency

Rare cause of the symptom triad

  • Wie lautet Ihre Diagnose?
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7

Literatur

  1. Kampmann C, Beck M, Morin I, Loehr JP (2011) Prevalence and characterization of cardiac involvement in Hunter syndrome. J Pediatr 159(2):327–331

    Article  PubMed  Google Scholar 

  2. Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Münzer J (2008) Initial report from the Hunter Outcome Survey. Genet Med 10(7):508–516. doi:10.1097/gim.0b013e31817701e6

    Article  PubMed  Google Scholar 

  3. Sohn YB et al (2011) Retrospective analysis of the clinical manifestations and survival of Korean patients with mucopolysaccharidosis type II: Emphasis on the cardiovascular complication and mortality cases. Am J Med Genet A 158A(1):90–96. doi:10.1002/ajmg.a.34371

    Article  PubMed  Google Scholar 

  4. Brands MMG, Frohn-Mulder IM, Hagemans MLC, Hop WCJ, Oussoren E, Helbing WA, van der Ploeg AT (2013) Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI. J Inherit Metab Dis 36:227–234

    Article  CAS  PubMed  Google Scholar 

  5. Lin HY, Chuang CK, Chena MR, Lin SM, Hung CL, Chang CY, Chiu PC, Tsai WH, Niu DM, Tsai FJ, Lin SJ, Hwu WL, Lin JL, Lin SP (2016) Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI. Mol Genet Metab 117:431–437

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kardiologie, Krankenhaus Bad Arolsen, Große Allee 50, 34454, Bad Arolsen, Deutschland

    B. Linder & A. Gabitov

  2. Kinderklinik, Stoffwechselzentrum und Zentrum für seltene Erkrankungen, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    A. M. Das

Authors
  1. B. Linder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gabitov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to B. Linder or A. M. Das.

Ethics declarations

Interessenkonflikt

B. Linder, A. Gabitov und A.M. Das geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Alle Patienten, die über Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.

Additional information

Redaktion

P. Stawowy, Berlin

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Linder, B., Gabitov, A. & Das, A.M. Hypertensive Herzerkrankung, Linksherzhypertrophie und Herzklappeninsuffizienz. Kardiologe 11, 56–60 (2017). https://doi.org/10.1007/s12181-016-0091-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-016-0091-3

Search

Navigation